Ministry of Investment of Saudi Arabia and Janssen kickstart a national campaign on the value of innovation in healthcare

Ministry of Investment of Saudi Arabia and Janssen kickstart a national campaign on the value of innovation in healthcare

Campaign’s multi-disciplinary steering committee to bring industry knowledge and expertise across the healthcare sector

Oloumak builds on earlier agreement signed between MISA and Janssen in June 2021 establishing a strategic partnership framework

Riyadh, KSA: The Ministry of Investment (MISA) and Janssen, the pharmaceutical companies of Johnson & Johnson, have launched Oloumak, a national multi-stakeholder campaign developed to shed light on the value of research, development, and innovation in healthcare and biotechnology in the Kingdom. In addition, the campaign aims to highlight the ways in which innovation in these vital industries fuels growth and economic transformation, and enhances patient care and quality of life.

MISA and Janssen will work together to put the Oloumak campaign at the forefront of governmental and non-governmental efforts to strengthen collaboration and raise awareness of the importance of improving quality of life and patient healthcare in Saudi Arabia.

Oloumak aims to develop meaningful momentum across the biomedical value chain in the Kingdom through a number of communication and awareness milestones. Through public and private sector partnerships, the campaign seeks to encourage and support innovation that will both stimulate the Kingdom’s economy and enhance its robust healthcare industry. It will specifically focus on the vital role of research and development in